Most recent analysis of LDN survey reveals relapse rate of 0.226 for 267 MS patients, or 1 relapse every 5 years. Same as Copaxone!
The other questions on symptoms are subjective of course, but are informative for LDN users, who want to compare their results to a block of users, broken down by MS type.
I hope these reports help convince anyone you are talking to about LDN, either for prescriptions or research.
I think I have done everything I can to wring useful data out of the survey. I hope this homemade research is useful to everyone in their pitch to researchers, as a valid clue that needs to be followed up. Now it is time for trails!
My deepest gratitude to all of you for your feedback and hard work on the LDN trials campaign!